VSTM
Verastem, Inc.
stockNASDAQ
At CloseOct 30, 2026 4:49:30 PM EDT
9.56USD-1.035%(-0.10)2,411,811
Pre-marketOct 30, 2026 10:29:29 AM EDT
9.59USD-0.725%(-0.07)
Loading…
Loading…
1.18B
Healthcare
Biotechnology
HQ
Needham, MA, USA
Previous Close
$9.66
Beta
1.03
52-Week High
$10.82 2025-11-26
52-Week Low
$3.43 2026-06-25
SMA 50
$8.16
SMA 200
$6.17
Avg. Vol 10D
3.63M
Avg. Vol 30D
4.56M
Avg. Vol 90D
3.17M
Relative Vol
0.53
121.50M
79.89M
65.75%
17,201,810
24.40%
2.49
56%/44%
49.32%
37.10%
0.4100%
2,500,000
107,998
118,293
216,889
Nov 5, 2026 (4d)
Jun 1, 2023 · 1-for-12 (reverse)
87.5M
-202.7M
-182.57
-471.16
Oct 28, 2026
Novocure partners with Verastem on pancreatic cancer trial · 
Investing.com
Oct 22, 2026
Oct 16, 2026
Wainwright reiterates Verastem stock rating on China trial data · Investing.com
Oct 15, 2026
Verastem’s KRAS inhibitor posts wins in mPDAC, mCRC and NSCLC · 
Clinical Trials Arena
VSTM Profile
verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com
VSTM Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 10.04 | 2026-10-23 | -3.49% | -0.458 |
| 1M | 7.90 | 2026-10-01 | +22.66% | -0.002 |
| 3M | 5.80 | 2026-07-31 | +67.07% | 0.570 |
| 6M | 5.84 | 2026-05-01 | +65.92% | 0.431 |
| 1Y | 9.45 | 2025-10-31 | +2.54% | 1.028 |
| 2Y | 3.76 | 2024-10-31 | +157.71% | — |
| 5Y | 32.40 | 2021-11-01 | -70.09% | 1.528 |
VSTM Stock Summary
Verastem, Inc. (NASDAQ:VSTM) stock price today is $9.69, and today's volume is 2,411,811. VSTM is up 0.311% today. The 30 day average volume is 4.56M. VSTM market cap is $1.18B with 121.50M shares outstanding.